Translate this page into:
Raising chronic obstructive pulmonary disease awareness in Africa: Time to walk the talk
*Corresponding author: Obianuju B. Ozoh, Department of Medicine, College of Medicine, University of Lagos, Lagos, Nigeria. oozoh@unilag.edu.ng
-
Received: ,
Accepted: ,
How to cite this article: Ozoh OB, Ogundare A, Ozoh CT, Tekobo A. Raising chronic obstructive pulmonary disease awareness in Africa: Time to walk the talk. J Pan Afr Thorac Soc. 2024;5:89-91. doi: 10.25259/JPATS_28_2024
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death globally, and its prevalence is increasing.[1] Sub-Saharan Africa (sSA) currently bears the highest burden, and this is projected to grow in the coming decades.[2,3] Increased survival and aging of the population, together with rising exposure to risk factors such as air pollution and tobacco smoking, are driving this trend.[4] Low socioeconomic status and previous pulmonary tuberculosis, which are endemic in sSA, are additional risk factors.[5,6]
Most COPD deaths occur in low-income to middle-income countries (LMICs), and there are many underpinnings to this.[7] Underdiagnosis and late presentation to the hospital, coupled with weak health systems and limited access to diagnostic and treatment facilities, are important factors.[8] More upstream factors include low awareness and prioritization of COPD as a public health problem by policymakers, which limits the allocation of resources for disease prevention, diagnosis, and treatment.[8]
The Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) produces an evidence-based strategy to guide the diagnosis and treatment of COPD. An executive summary of the 2023 version of the guideline is published in this issue of the journal.[9] The GOLD strategy is designed and expected to inform the development of context-based local COPD guidelines. Nonetheless, only a few African countries have national COPD guidelines, and many do not specifically include medicines for COPD on the Essential Medicine List.[10]
COPD underdiagnosis is a global challenge, more so in the African continent, where about 99% of people with COPD in epidemiological studies were not previously diagnosed or treated.[11,12] Underdiagnosis is a consequence of failure to present to the healthcare facility for evaluation and diagnosis, either due to the lack of recognition or understanding of the symptoms or limited access to healthcare services. It could also stem from misdiagnosis by a healthcare professional with poor knowledge about the disease or lack of access to necessary diagnostic facilities. Underdiagnosis bodes for poor outcomes because it results in inappropriate treatment or no treatment at all.
Low population literacy and poor knowledge among doctors are important factors contributing to COPD underdiagnosis in Africa and other LMICs.[13,14] Population literacy about a disease drives health-seeking behavior, adherence to treatment, and allocation of resources for care. In a population-based survey in India, <1% of the participants were aware of COPD as a disease affecting the lungs.[14] In Africa, doctors’ knowledge and practice about COPD diagnosis and treatment are low, particularly among those practicing in primary and secondary healthcare facilities, where most of the population seek care.[13]
Against this backdrop, GOLD is partnering with the Pan African Thoracic Society to deliver a program aimed at improving COPD outcomes in Africa. This program titled, Raising COPD Awareness in Africa (RACE Africa), aims to improve doctors’ knowledge and practice and community literacy about COPD in six African cities: Lagos, Nigeria; Port Harcourt, Nigeria; Addis Ababa, Ethiopia; Doula, Cameroon; Ouagadougou, Burkina Faso; and Kigali, Rwanda. It comprises a series of doctors’ education workshops on COPD diagnosis and treatment, including training on screening symptomatic patients for COPD. Through the training and ongoing support for doctors practicing in primary and secondary care facilities, a pathway for spirometry referrals has been established. We are also conducting community surveys to understand the current level of COPD awareness to quantify the magnitude of the problem in Africa. We have developed and are distributing educational materials, including videos (https://www.instagram.com/reel/DDuQBG-q9jm/?igsh=cm83a3JudGsxbGlu), flyers, and posters [Figure 1] in many languages about symptoms, risk factors, prevention, and treatment of COPD across communities and on social media.
As the United Nations and the global community work toward reducing the burden of non-communicable diseases by 30% in 2030, there is a need for all stakeholders to begin to “walk the talk” toward achieving this sustainable development goal.[15] RACE Africa is an example of how international organizations could partner with regional societies to improve COPD outcomes in LMICs. By improving COPD awareness and knowledge in Africa, we expect a rising demand for COPD diagnostics and treatment that will drive policy toward prioritization and optimization of services and hopefully stem the tide in disease burden.
References
- Washington: Institute for Health Metrics and Evaluation. 2021 Available from: https://www.healthdata.org/research-analysis/library/global-burden-disease-2021-findings-gbd-2021-study [Last accessed on 2024 Jun 20]
- [Google Scholar]
- Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: A systematic review and modelling analysis. Lancet Respir Med. 2022;10:447-58.
- [CrossRef] [PubMed] [Google Scholar]
- Global burden of chronic obstructive pulmonary disease through 2050. JAMA Netw Open. 2023;6:e2346598.
- [CrossRef] [PubMed] [Google Scholar]
- Burden and risk factors of chronic obstructive pulmonary disease in Sub-Saharan African countries, 1990-2019: A systematic analysis for the Global Burden of disease study 2019. EClinicalMedicine. 2023;64:102215.
- [CrossRef] [PubMed] [Google Scholar]
- Household air pollution and COPD: Cause and effect or confounding by other aspects of poverty? Int J Tuberc Lung Dis. 2022;26:206-16.
- [CrossRef] [PubMed] [Google Scholar]
- Tuberculosis associates with both airflow obstruction and low lung function: BOLD results. Eur Respir J. 2015;46:1104-12.
- [CrossRef] [PubMed] [Google Scholar]
- Chronic obstructive pulmonary disease (COPD) Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd) [Last accessed on 2022 May 01]
- [Google Scholar]
- The global state of COPD: Driving change to tackle a lung health crisis London: The Health Policy Partnership; 2024.
- [Google Scholar]
- Global initiative for chronic obstructive lung disease 2023 report: Gold executive summary. J Pan Afr Thorac Soc. 2024;4:92-114.
- [CrossRef] [PubMed] [Google Scholar]
- Gaps in COPD guidelines of low-and middle-income countries. Chest. 2021;159:575-84.
- [CrossRef] [PubMed] [Google Scholar]
- Chronic airflow obstruction in a black African population: Results of BOLD study, Ile-Ife, Nigeria. COPD. 2016;13:42-9.
- [CrossRef] [PubMed] [Google Scholar]
- Unmet diagnostic and therapeutic opportunities for COPD in low-and middle-income countries. Am J Respir Crit Care Med. 2023;208:442-50.
- [CrossRef] [PubMed] [Google Scholar]
- A survey of the knowledge of general practitioners, family physicians and pulmonologists in Nigeria regarding the diagnosis and treatment of chronic obstructive pulmonary disease. West Afr J Med. 2014;33:100-6.
- [Google Scholar]
- COPD awareness in the urban slums and rural areas around Pune city in India. NPJ Prim Care Respir Med. 2021;31:6.
- [CrossRef] [PubMed] [Google Scholar]
- Transforming our World: The 2030 agenda for sustainable development. 2015. Sustainable Development Knowledge Platform. Available from: https://sustainabledevelopment.un.org/post2015/transformingourworld/publication [Last accessed on 2022 Mar 08]
- [Google Scholar]